Last reviewed · How we verify
NCT04523311
An Evaluation of Brief Online Hypnosis for Migraine and Tension-type Headaches
NA trial testing Hypnosis. in Migraine in 35 participants. Completed in 24 February 2021.
24 February 2021
Quick facts
| Lead sponsor | Canterbury Christ Church University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 35 |
| Start date | 27 October 2020 |
| Primary completion | 24 February 2021 |
| Estimated completion | 24 February 2021 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Hypnosis.
- Usual care
Conditions studied
- Migraine — all drugs for Migraine →
- Tension-Type Headache — all drugs for Tension-Type Headache →
Sponsor
Canterbury Christ Church University
Who can join
Adults 18 to 80, any sex, with Migraine or Tension-Type Headache. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to conduct an initial evaluation of whether a single, online, group-based session of hypnosis followed by self-hypnosis can decrease symptoms of migraine and tension-type headaches as well as improve quality of life and perceived self-efficacy over the condition.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04523311
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Migraine
Currently open trials in the same condition.
- NCT07419607 — MIGRAFIT: Evaluating a Group Therapy Program Combining Physical Activity, Progressive Muscle Relaxation and Psychoeducat · NA · recruiting
- NCT07487701 — Migraine Prevention With the Remote Electrical Neuromodulation (REN) Wearable: A Real-world Evidence Study · NA · active not recruiting
- NCT07343427 — Impact of GON PRF on Central Sensitization in Migraine Patients · NA · active not recruiting
- NCT07336056 — Nerivio Efficacy Under High-Frequency Use · Phase 4 · active not recruiting
- NCT07385755 — Desvenlafaxine for Preventive Treatment of Frequent Migraines · NA · active not recruiting
Other Canterbury Christ Church University trials
Trials by the same sponsor.
- NCT06402461 — Comparing Random Allocation and Allocation by Preference to Mindfulness Practice · NA · completed
- NCT07051005 — Feasibility of a Tailored Online Self-compassion Intervention · NA · recruiting
- NCT06821841 — Online Physical Activity Intervention for Peri- and Post-menopausal Working Women · NA · completed
- NCT06835777 — Neurophysiological Mechanisms of Placebo and Nocebo Effects in Sports - a Protocol Paper · NA · not yet recruiting
- NCT05749029 — An Online, Compassion Intervention for Adults with Type 1 and Type 2 Diabetes Mellitus (T1DM; T2DM). · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04523311 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Canterbury Christ Church University
- Last refreshed: 27 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04523311.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing